HERC2 and neoplasm: Our data reveal a new mechanism by which HERC2 deficiency may contribute to tumour malignancy by impairing p53 transcriptional activity, and also by boosting the cellular antioxidant response making cancer cells more resistant to oxidative stress (Fig. 8).